CORC

浏览/检索结果: 共39条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Interaction of estrogen receptor 5 and interleukin 6 receptor in the progression of non-small cell lung cancer 期刊论文
JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 卷号: 120, 期号: 2
作者:  Tang, Hexiao;  Bai, Yuquan;  Xiong, Lecai;  Zhang, Li;  Wei, Yanhong
收藏  |  浏览/下载:31/0  |  提交时间:2019/12/05
Developmental exposure to BDE-99 hinders cerebrovascular growth and disturbs vascular barrier formation in zebrafish larvae 期刊论文
AQUATIC TOXICOLOGY, 2019, 卷号: 214
作者:  Zhong, Xiali;  Kang, Jianmeng;  Qiu, Jiahuang;  Yang, Wenhan;  Wu, Jingwei
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/05
Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition) 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 卷号: 12
作者:  Li, Jian;  Yuan, Ying;  Yang, Fan;  Wang, Yi;  Zhu, Xu
收藏  |  浏览/下载:61/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:39/0  |  提交时间:2019/12/05
Network reconfiguration and operation optimisation of distribution system with flexible DC device 会议论文
作者:  Yang, Yanhong;  Zhang, Shizhong;  Pei, Wei;  Sun, Jianjun;  Lu, Yi
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:40/0  |  提交时间:2019/12/05
P21 and P27 promote tumorigenesis and progression via cell cycle acceleration in seminal vesicles of TRAMP mice 期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 卷号: 15, 期号: 10
作者:  Li, Tonghui;  Wang, Fangfang;  Dang, Yanmei;  Dong, Jiajie;  Zhang, Yu
收藏  |  浏览/下载:12/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:33/0  |  提交时间:2019/12/05
Exendin-4通过eNOS/cGMP/PKG途径和GLP-1受体抑制心力衰竭大鼠结构重塑并改善Ca2+稳态 会议论文
作者:  Jingjing-Chen;  Dandan-Wang;  Fangai-Wang;  Shaobo-Shi;  Yuting-Chen
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:31/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace